According to a recent LinkedIn post from Doccla, the company is involved in the Virtual Ward Programme at Our Lady of Lourdes Hospital in Drogheda, which is being highlighted by Ireland’s Health Service Executive (HSE) Technology and Transformation team. The post cites reported outcomes of 1,033 bed-days saved and 128 patients supported at home across multiple clinical pathways.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests that Doccla’s remote monitoring and virtual ward technology is being used at scale in cardiology, respiratory, stroke, infectious disease and general medicine, enabling full clinical oversight for patients at home. For investors, this visible integration into a national health system could indicate growing validation of Doccla’s model and potential for expanded deployments.
If such programmes are replicated across additional hospitals or regions, Doccla could benefit from recurring revenue streams tied to long-term service contracts and technology licensing. The emphasis on measurable operational benefits, such as bed-day savings, may also strengthen the company’s value proposition in procurement discussions and support competitive positioning within the virtual care sector.
More broadly, the focus on community-based care aligns with health system priorities to reduce pressure on acute hospital capacity and manage chronic conditions remotely. This positioning could make Doccla a beneficiary of ongoing digital health and virtual care investment trends, though the LinkedIn content does not provide specific financial metrics, contract values or growth projections.

